IDT Australia Ltd (IDT)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:IDT Australia Ltd (IDT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013550
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
IDT Australia Ltd (IDT) is a contract manufacturing company that specializes in the development, scale-up and production of active pharmaceutical ingredients (APIs), microbiological and analytical testing, clinical trial research services and pharmacy services. The company also specializes in the post-discovery pharmaceutical life cycle. It manages Cytotoxic API’s, high potency API’s, anti-cancer drugs, antibiotics, anti-psychotics, beta lactams and controlled drugs. IDT provides a wide range of services, which can be customized to meet the specific requirements of its customer. The company also provides specialist clinical trial labeling, packaging and dispensing services. IDT is headquartered in Boronia, Victoria, Australia.

IDT Australia Ltd (IDT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
IDT Australia Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
IDT Australia Acquires Generic Drugs from Global Generics Company for USD14.8 Million 10
IDT Australia to Acquire Synthetic Conjugated Estrogens from Perrigo 11
Partnerships 12
Mayne Pharma Enters into Distribution Agreement with IDT Australia 12
ANI Pharma Enters into Agreement with IDT Australia 13
Equity Offering 14
WellSpring Pharma Services Invests USD3 Million in IDT Australia 14
IDT Australia Completes Private Placement Of Shares For US$2.8 Million 15
IDT Australia Completes Private Placement Of Shares For US$0.8 Million 16
IDT Australia Completes Rights Offering Of Shares For US$1.8 Million 17
Asset Transactions 18
I’rom Group Completes Acquisition of CMAX Clinical Trial Business from IDT Australia 18
Acquisition 19
I’rom Group to Acquire 61% Stake in CMAX from IDT Australia for USD7.6 Million 19
I’rom Completes Acquisition Of 18.8% Stake In IDT Australia For US$2 Million 20
IDT Australia Ltd – Key Competitors 21
IDT Australia Ltd – Key Employees 22
IDT Australia Ltd – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Strategy And Business Planning 24
Mar 30, 2016: IDT Greatly Expands Generics Production Capacity with New Manufacturing Partner 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
IDT Australia Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
IDT Australia Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
IDT Australia Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
IDT Australia Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
IDT Australia Acquires Generic Drugs from Global Generics Company for USD14.8 Million 10
IDT Australia to Acquire Synthetic Conjugated Estrogens from Perrigo 11
Mayne Pharma Enters into Distribution Agreement with IDT Australia 12
ANI Pharma Enters into Agreement with IDT Australia 13
WellSpring Pharma Services Invests USD3 Million in IDT Australia 14
IDT Australia Completes Private Placement Of Shares For US$2.8 Million 15
IDT Australia Completes Private Placement Of Shares For US$0.8 Million 16
IDT Australia Completes Rights Offering Of Shares For US$1.8 Million 17
I'rom Group Completes Acquisition of CMAX Clinical Trial Business from IDT Australia 18
I’rom Group to Acquire 61% Stake in CMAX from IDT Australia for USD7.6 Million 19
I'rom Completes Acquisition Of 18.8% Stake In IDT Australia For US$2 Million 20
IDT Australia Ltd, Key Competitors 21
IDT Australia Ltd, Key Employees 22

★海外企業調査レポート[IDT Australia Ltd (IDT)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Banque Internationale à Luxembourg SA:企業の戦略・SWOT・財務情報
    Banque Internationale à Luxembourg SA - Strategy, SWOT and Corporate Finance Report Summary Banque Internationale à Luxembourg SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Formosa Petrochemical Corp (6505):企業の財務・戦略的SWOT分析
    Formosa Petrochemical Corp (6505) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Australian Vanadium Ltd (YRR):企業の財務・戦略的SWOT分析
    Summary Australian Vanadium Ltd (AVL), formerly Yellow Rock Resources Ltd, is a mining company that explores and develops titanium, vanadium, copper, gold, and uranium metals. The company’s projects include Gabanintha Gold Copper Project, The Australian Vanadium Project, Coates Vanadium Project, Now …
  • Verisante Technology Inc (VRS)-医療機器分野:企業M&A・提携分析
    Summary Verisante Technology Inc (Verisante), develops and commercializes products for the early detection of all forms of skin cancer. The company’s key product offerings include Verisante Aura, Verisante Core and Verisante MSI Camera. The Verisante Aura is used for skin cancer detection, and Veris …
  • Simplex Infrastructures Ltd:企業の戦略・SWOT・財務分析
    Simplex Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report Summary Simplex Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Schweizerische Rettungsflugwacht:企業の戦略的SWOT分析
    Schweizerische Rettungsflugwacht - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Commonwealth Scientific and Industrial Research Organisation:医療機器:M&Aディール及び事業提携情報
    Summary Commonwealth Scientific and Industrial Research Organisation (CSIRO) is a national science agency that conducts research in climate adaptation, bio-security, renewable and energy, farming and food production, and information technology, and mining and manufacturing services, and others. The …
  • Navistar International Corp (NAV):企業の財務・戦略的SWOT分析
    Navistar International Corp (NAV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • American States Water Company (AWR):企業の財務・戦略的SWOT分析
    Summary American States Water Company (AWR) is a utility service provider that offers water, wastewater and electric services. The utility provides operation, construction management and maintenance services for water and wastewater systems located on military bases across the US. It offers water se …
  • Genicon Inc:医療機器:M&Aディール及び事業提携情報
    Summary Genicon Inc (Genicon) is a medical device company that designs, manufactures and distributes surgical instruments for laparoscopic surgery. The company provides products such as port systems, suction and irrigation, instrumentation, ligation and other surgical instruments. It provides port s …
  • Oncodesign SA (ALONC):製薬・医療:M&Aディール及び事業提携情報
    Summary Oncodesign SA (Oncodesign) is a biopharmaceutical company, specializing in precision medicine offers drug discovery and pharmacological evaluation services for cancer. Its service offerings include integrated drug discovery; metabolic and pharmacokinetic characteristics of chemical and biolo …
  • Indena SpA:企業の戦略的SWOT分析
    Indena SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • MiMedx Group Inc (MDXG):企業の財務・戦略的SWOT分析
    Summary MiMedx Group Inc (MiMedx) develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary purion process that separates placental …
  • AutoZone Inc (AZO):企業の財務・戦略的SWOT分析
    AutoZone Inc (AZO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Generali France S.A.:企業の戦略・SWOT・財務分析
    Generali France S.A. - Strategy, SWOT and Corporate Finance Report Summary Generali France S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bank Of Ireland (Uk) Plc:企業の戦略・SWOT・財務分析
    Bank Of Ireland (Uk) Plc - Strategy, SWOT and Corporate Finance Report Summary Bank Of Ireland (Uk) Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Fingrid Oyj:企業の戦略的SWOT分析
    Fingrid Oyj - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Pt Indofood Sukses Makmur Tbk:企業の戦略・SWOT・財務分析
    Pt Indofood Sukses Makmur Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Indofood Sukses Makmur Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Nuevolution AB (NUE):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuevolution AB (Nuevolution) is a biopharmaceutical company focused on developing drug treatments for cancer and chronic inflammatory diseases. The company’s pipeline products include RORyt inhibitor, BRD (BD1), cytokine X, RORyt agonist, and GRP78. Its products are used for various indicati …
  • SGS SA (SGSN):医療機器:M&Aディール及び事業提携情報
    Summary SGS SA (SGS) is a provider of inspection, verification, testing, certification and quality assurance services. The company also provides risk management, consultancy, sustainability solutions and training services. SGS inspects, samples, analyzes, and monitors raw materials, components and p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆